GLP-1 users open up online about their anhedonia, a side effect that prevents them from enjoying or being interested in activities that once felt rewarding
Weight-loss drugs and anti-aging treatments are shaping contemporary culture. New works of fiction portray a society terrified of fat, aging and any body that deviates from the norm
More than 3,000 genetic variants influence a person’s susceptibility to weight gain. That inherited risk has become even more significant due to environmental factors
A population study indicates that the link between impulsivity, alcohol, and violence falls by as much as 62% among users of these drugs
A new study shows the presence of certain biomarkers increases the risk of memory and cognitive problems among the middle-aged — and in the future, widespread screening may be available
A study shows obesity trends have diverged across regions over the past four decades, though it is too early for drugs such as Ozempic to have had a measurable impact
Supplements based on this alkaloid have shown some benefits, but they are not comparable to GLP-1-based drugs
Women have long gone to extreme lengths to fit into their era’s beauty canon — let’s examine the truths and lies behind the supposed Ozempic of the Victorian era
Director Chloé Wallace speaks out against the rise of ‘heroin chic’ and opens the debate about the dangers of body worship and the ultraconservative gaze behind the return to that ideal of beauty
Live fast, die old. This could be the premise of the work by this researcher, who tries to unravel the secrets of centenarians who are in good health despite a lifestyle that cannot always be considered a model to follow
Pharmaceutical trafficking is becoming a public health problem, say medical authorities and patients
Organoids, which the professor is researching, are transforming drug experimentation
Is the success of this drug due to a society that is more health-conscious, or just more concerned with aesthetics?
A small-scale study suggests that patient psychology may limit the effectiveness of GLP-1 agonist medications
A nutritionist, a sociologist and a gastronomic consultant help us understand the impact of GLP-1 agonists on the food establishments. Some are starting to offer smaller menus for those whose appetite has shrunk
A retrospective macro-study revealed that the use of GLP-1 agonists is associated with a reduction in the overall risk of cancer among obese or overweight patients
Recently, the provocateur has gone from being a marginal figure of the so-called ‘Dark Enlightenment’ to placing himself at the center of the American ideological war, cast as a kind of oracle to the MAGA universe
The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he remains cautious about their use
As anti-obesity drugs gain traction and thinness is increasingly equated with health, the movement to accept diverse body types is being sidelined
The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant alarm
An analysis of thousands of people suggests that these strategies, especially eating every other day, are an alternative to traditional weight loss methods
Novo Nordisk’s campaign, which aims to speak ‘without filters’ by declaring obesity a disease, has been strongly criticized on social media: ‘It’s indecent’
A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction
New research shows that this method leads to greater weight loss and improved metabolism. Possible rebound effects were not analyzed
The next generation of treatments aims to help patients lose a quarter of their weight
The writer has published ‘Magic Pill,’ a book where based on his own experience with weight-loss drugs he embarks on a journey about the impact of these revolutionary treatments
Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema
